Skip to main content
. 2020 Aug 2;80:100876. doi: 10.1016/j.preteyeres.2020.100876

Table 14.

Special regulatory issues in clinical trials of xenotransplantation.

Uncertainty of risks to the public
Porcine endogenous retrovirus and other new infection outbreak
Regulatory oversight
Long-term follow-up
Even life-long surveillance and after death
Feasibility of the follow-up system
Add-on consent from the close contacts of the subject
Risks of zoonotic infection to the close contacts
Share the obligations of the subject with closer contacts (usually family members)